Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco Europe Enhanced Equity UCITS ETF Acc

IQEA · IE000YNVI4W4 · class Acc · EUR · domicile Ireland
Equity · EuropeactiveSFDR art. 8
Comparison benchmark: MSCI Europe Total Return (Net) Index
TER
0.24%+ trans. 0.17%
Fund size
293 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Activeactive management
Income
Accumulating
Launch 16 Sept 2025 · costs from the KID as of 14 Aug 2026 · 246 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve a long-term return in excess of the Benchmark (the MSCI Europe Index) by investing in an actively managed portfolio of European equities. Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives. Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are…

Performance since series start (in euro) — base 100

16 Sept 20253 Sept 2026 · dividends reinvested where declared by the issuer
2026125100124
High 125 (13 Aug 2026) · low 100 (17 Sept 2025) · last 124. Past performance is not indicative of future results.

Returns in euro

1 year+23.8%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+23.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.48%12.48%
Max drawdown−9.13%−9.13%
Sharpe1.631.63
Sortino2.562.56
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IQEA · IE000YNVI4W41
RebalixIQEA · IE000YNVI4W4 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 246 securities · top-10 weight = 22.7%
Top holdingsWeight
ASML HOLDING NV EUR0.094.6%
HSBC HOLDINGS PLC GBP 0.50002.6%
NOVARTIS AG-REG CHF0.52.5%
SHELL PLC GBP 0.07002.3%
ROCHE HOLDINGS AG CHF NPV2.3%
NESTLE SA-REG CHF0.11.9%
ALLIANZ SE-REG NPV1.8%
ASTRAZENECA PLC USD0.251.7%
SIEMENS AG-REG NPV1.6%
BANCO SANTANDER SA EUR0.51.4%
Countries (% of fund)
United Kingdom15.5%Germany13.5%France13.1%Other13.0%United States12.9%
Sectors (% of fund)
Financials26.9%Industrials19.1%Health Care11.7%Information Technology7.9%Consumer Staples7.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
IQEA · Borsa Italiana (ETFplus)
IQHE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 12 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE000YNVI4W4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IQEA · IE000YNVI4W42